Carolyn S. P. Lam MBBS, PhD, FRCP, MS, FACC, FAMS, FESC
Cardiology Division, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts; Senior Consultant Cardiologist, National Heart Centre Singapore; Professor, Duke-National University of Singapore, SingaporeDr. Lam is a Professor at Duke-National University of Singapore and Senior Consultant Cardiologist at the National Heart Centre Singapore specializing in heart failure. She is an experienced clinical trialist with particular expertise in heart failure with preserved ejection fraction (HFpEF), as well as regional/ ethnic differences in heart failure.
Dr. Lam is also a long-standing advocate for women’s heart health, and is passionate about about investigating sex differences in cardiovascular disease, including the role of gender disparities. She established the first Women’s Heart Clinic in Singapore in 2011 and served as Commissioner for The Lancet’s Commission for Women and Cardiovascular Disease.
She was appointed to the 2021-22 European Society of Cardiology Heart Failure Guidelines Task Force, is recognized as Clarivate’s Highly cited Researcher 2021, 2022 and 2023 in Clinical Medicine, and is lead author of the chapter on HFpEF for Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, 12th Edition.
Disclosures
Dr. Lam is supported by a Clinician Scientist Award from the National Medical Research Council of Singapore; has Received research support from NovoNordisk and Roche Diagnostics; has Served as consultant or on the Advisory Board/ Steering Committee/ Executive Committee for Alleviant Medical, Allysta Pharma, AnaCardio AB, Applied Therapeutics, AstraZeneca, Bayer, Biopeutics, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, CardioRenal, Cytokinetics, Darma Inc., EchoNous Inc, Eli Lilly, Impulse Dynamics, Intellia Therapeutics, Ionis Pharmaceutical, Janssen Research & Development LLC, Medscape/WebMD Global LLC, Merck, Novartis, Novo Nordisk, Prosciento Inc, Quidel Corporation, Radcliffe Group Ltd., Recardio Inc, ReCor Medical, Roche Diagnostics, Sanofi, Siemens Healthcare Diagnostics and Us2.ai; and serves as co-founder & non-executive director of Us2.ai.